Segra International Corp.

Segra International Corp. , based in Canada, specializes in advanced plant tissue culture and diagnostic services tailored specifically for the cannabis industry, enhancing cultivation practices and ensuring high-quality output. Founded in 2014 and headquartered in Richmond, Canada, Segra International Corp. focuses on advanced plant tissue culture for the cannabis sector.

The company's founder is Todd McMurray, and it is led by CEO Jamie Blundell. Segra has engaged in 2 deals, with the most recent occurring on April 20, 2021, when it raised USD 1. 23 mn in a funding round. Segra International specializes in advanced plant tissue culture and diagnostic services tailored for the cannabis industry.

Their core product offerings include plantlets, cannabis tissue culture, and genetic identification technologies. Segra’s proprietary DNA Fingerprinting technology enables cultivators to maintain rigorous quality assurance by accurately identifying disease-free genetic stock from an expansive library of cannabis cultivars, primarily serving cannabis growers in North America. Segra International employs a B2B transaction model, generating revenue through the sale of tissue culture services and diagnostic tools essential for maintaining disease-free plant stock. Clients typically order specific quantities of plantlets or diagnostic services through contractual agreements, with pricing structures based on the type and volume of services rendered, ensuring access to high-quality starting materials while fostering long-term relationships.

In April 2021, Segra International Corp. raised USD 1. 23 mn in venture funding to support the development of its plant and geographic expansion initiatives. The company plans to introduce new products and expand its services into additional markets, enhancing its presence in the cannabis cultivation sector.